Skip to main content
Caplight Logo









InSphero

InSphero

Private
SchlierenHealthcare & Life Scienceshttps://insphero.com/

Last Round

Series D

Mar 31, 2023

Total Funding Raised

$26.49M

Company Overview

InSphero is a biotechnology company that develops and provides 3D cell-based assay and organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

3D microtissuesorgan-on-a-chipOOCcontract research organizationCROorganoidsspheroidspreclinical testingdrug discovery servicesnew approach methodologiesNAMssafety testingin-vitro modelstoxicology servicestox testingphenotypic screeningliver modelsoncology modelsAI-assisted analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InSphero Comparables

Compare InSphero with similar companies based on industry and business-model similarity.

InSphero comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MIMETAS
88%
Emulate
86%
CN Bio
85%

InSphero Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 31, 2023
GrantJan 23, 2023
VC RoundJun 13, 2018
Series CJul 8, 2015
Series BJun 18, 2013
Series A
Aug 5, 2010

InSphero Investors

Notable investors and investment history

InSphero investors
InvestorRounds
Eurostars SME programmeGrant
InnosuisseGrant
RedalpineVC Round, Series A
BpifranceGrant
OCCIDENTSeries D
Zurcher KantonalbankVC Round, Series A
ZEISS VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors grew 54% MoM.

  • Mar 31, 2023

    ZEISS Ventures led the Series D round.

InSphero Filings

Explore SEC and related filing metadata, where available.

InSphero filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InSphero's valuation, stock price, and market status.

Is InSphero a public or private company?

InSphero is a private company.

What is the current stock price of InSphero?

InSphero is a private company with no public stock price. No recent secondary market data is available.

How much is InSphero worth (valuation)?

Valuation information for InSphero is not publicly available.

Can I buy InSphero stock?

InSphero shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was InSphero's last funding round?

InSphero's most recent funding round was Series D on March 31, 2023.

Who are the main investors in InSphero?

Key investors in InSphero include Redalpine, ZEISS Ventures.

Will InSphero IPO soon?

No public IPO plans have been announced for InSphero.

How can I track InSphero secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InSphero's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSchlieren
Employee Range75
Year Founded2009
Last FundingMar 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?